Skip to main content
. Author manuscript; available in PMC: 2023 Aug 10.
Published in final edited form as: J Nephrol. 2015 Mar 10;28(6):739–747. doi: 10.1007/s40620-015-0188-y

Table 2.

Cardiac function parameters in patients with and without LVDD

Totala Patients with LVDD (n = 40)a Patients without LVDD (n = 42)a p valueb
SVI (ml/m2) 28.3 ± 14.6 25.8 ± 13.2 30.7 ± 15.7 0.144
COI (l/m2) 2.2 ± 21.3 2.1 ± 1.1 2.2 ± 1.5 0.910
EF (%) 58.8 ± 18.4 58.4 ± 19.7 59.2 ± 17.3 0.857
FS (%) 31.3 ± 14.3 30.5 ± 15.2 32.1 ± 13.5 0.648
LVMI (g/m2.7) 74.9 ± 40.5 75.8 ± 40.8 73.9 ± 40.6 0.829
LVH (n, %) 62 (87 %) 32 (80 %) 30 (71.4 %) 0.096
E/A 1.1 ± 0.4 1.1 ± 0.5 1.0 ± 0.3 0.336
E′ (cm/s) 11.0 ± 5.0 8.8 ± 3.9 13.0 ± 5.0 <0.001*
A′ (cm/s) 11.7 ± 4.8 10.5 ± 4 12.7 ± 5.1 0.039*
E/E′ 7.6 ± 4.3 10.1 ± 4.8 5.5 ± 2.3 <0.001*
DT of E (ms) 164.4 ± 75.0 157.1 ± 63.0 171.4 ± 85.1 0.390
LVSD (n) 10 5 5 0.868

LVDD left ventricular diastolic dysfunction, SVI stroke volume indexed by BSA, COI cardiac output indexed by BSA, EF ejection fraction, FS fractional shortening, LVMI left ventricular mass index, LVM/height2.7, LVH left ventricular hypertrophy, E/A the ratio of early/late diastolic mitral valve flow velocity, E′ peak early diastolic mitral annulus velocity, A′ peak late diastolic mitral annulus velocity, DT of E deceleration time of early diastolic mitral valve flow (E), LVSD left ventricular systolic dysfunction

*

Statistical significance between groups

a

Data expressed as mean ± SD for continuous values and a number for countable values

b

p-value for group differences between patients with and without LVDD